Introduction to Harrow Health Inc.
Harrow Health, Inc. (HROW) owns a diversified portfolio of healthcare businesses, including the nation's leading ophthalmic pharmaceutical compounding business, ImprimisRx®. The company holds large equity positions in Eton Pharmaceuticals (ETON), Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals, and Radley Pharmaceuticals, companies founded as subsidiaries of Harrow. Harrow Health boldly states their vision is to build, grow and invest in paradigm shifting businesses that put patients first. 89% of Harrow Health's revenue comes from their fully owned subsidiary, ImprimisRx, which offers 25 unique compounded formulations prescribed for many